Search

everythinglearnresearchcommunity

for

Search:↓

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The normal human prostate does not significantly affect blood DHT levels.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Finasteride helps reduce heart enlargement in heart failure patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New compounds may help treat prostate cancer by reducing cell growth.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride improves heart function and repairs damage after heart attack in mice.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Large prostate links to more hair loss, but age of onset doesn't affect it.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Using finasteride or dutasteride does not increase the risk of male breast cancer.